microRNA Biomarkers as Potential Diagnostic Markers for Cancer - Genomic Biomarkers for Pharmaceutical Development - page 116

[38] Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Standards for Reporting of
Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD
initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003;49:1-6.
[39] Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, et al. The microarray quality control (MAQC)
project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol
2006;24:1151-61.
[40] Archer KJ, Dumur CI, Taylor GS, Chaplin MD, Guiseppi-Elie A, Grant G, et al. Application of a correlation
correction factor in a microarray cross-platform reproducibility study. BMC Bioinformatics 2007;8:447.
[41] Yauk CL, Berndt ML. Review of the literature examining the correlation among DNA microarray technolo-
gies. Environ Mol Mutagen 2007;48:380-94.
[42] Fan X, Lobenhofer EK, Chen M, Shi W, Huang J, Luo J, et al. Consistency of predictive signature genes and
classiiers generated using different microarray platforms. Pharmacogenomics J 2010;10:247-57.
[43] Sah S, McCall MN, Eveleigh D, Wilson M, Irizarry RA. Performance evaluation of commercial miRNA
expression array platforms. BMC Res Notes 2010;3:80.
[44] Dallas PB, Gottardo NG, Firth MJ, Beesley AH, Hoffmann K, Terry PA, et al. Gene expression levels assessed
by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate?
BMC Genomics 2005;6:59.
[45] Canales RD, Luo Y, Willey JC, Austermiller B, Barbacioru CC, Boysen C, et al. Evaluation of DNA microarray
results with quantitative gene expression platforms. Nat Biotechnol 2006;24:1115-22.
[46] Chen Y, Gelfond JA, McManus LM, Shireman PK. Reproducibility of quantitative RT-PCR array in miRNA
expression proiling and comparison with microarray analysis. BMC Genomics 2009;10:407.
[47] Gyorffy B, Molnar B, Lage H, Szallasi Z, Eklund AC. Evaluation of microarray preprocessing algorithms
based on concordance with RT-PCR in clinical samples. PloS One 2009;4:e5645.
[48] Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identii-
cation of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008;14:844-52.
[49] Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al. A novel and universal
method for microRNA RT-qPCR data normalization. Genome Biol 2009;10:R64.
[50] Latham GJ. Normalization of microRNA quantitative RT-PCR data in reduced scale experimental designs.
Methods Mol Biol 2010;667:19-31.
[51] Benes V, Castoldi M. Expression proiling of microRNA using real-time quantitative PCR, how to use it and
what is available. Methods 2010;50:244-9.
[52] Wylie D, Shelton J, Choudhary A, Adai AT. A novel mean-centering method for normalizing microRNA
expression from high-throughput RT-qPCR data. BMC Res Notes 2011;4:555.
[53] Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of
real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol
2002;3(7) RESEARCH0034.
[54] Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data:
a model-based variance estimation approach to identify genes suited for normalization, applied to bladder
and colon cancer data sets. Cancer Res 2004;64:5245-50.
[55] Dunn BK, Wagner PD, Anderson D, Greenwald P. Molecular markers for early detection. Semin Oncol
2010;37:224-42.
[56] Ludwig JA, Weinstein JN. Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer
2005;5:845-56.
[57] Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and
management of pancreatic adenocarcinoma: an evidence based appraisal. J Gastrointest Oncol 2012;3:105-19.
[58] Cancer Facts & Figures 2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/
documents/document/acspc-031941.pdf
[59] Fuhrman GM, Charnsangavej C, Abbruzzese JL, Cleary KR, Martin RG, Fenoglio CJ, et al. Thin-section
contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neo-
plasms. Am J Surg 1994;167:104-11; discussion 111-3.
[60] Chang KJ, Nguyen P, Erickson RA, Durbin TE, Katz KD. The clinical utility of endoscopic ultrasound-
guided ine-needle aspiration in the diagnosis and staging of pancreatic carcinoma. Gastrointest Endosc
1997;45:387-93.